SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002475
Filing Date
2020-04-21
Accepted
2020-04-21 16:00:57
Documents
5
Period of Report
2020-06-10
Effectiveness Date
2020-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241362zdef14a.htm DEF 14A 846921
2 G772753.JPG g772753.jpg GRAPHIC 15169
3 G20732BII001.JPG g20732bii001.jpg GRAPHIC 51727
4 G20732BII002.JPG g20732bii002.jpg GRAPHIC 87979
5 G20732BII003.JPG g20732bii003.jpg GRAPHIC 112632
  Complete submission text file 0001047469-20-002475.txt   1216917
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37508 | Film No.: 20805162
SIC: 2834 Pharmaceutical Preparations